Prevalence of self-injurious behavior in people with intellectual development disorder

Ianni, Humberto F.; Abreu, Thiago C.; Fidelis, Sarah de M.; Corrêa, Humberto; Kümmer, Arthur

doi:10.1590/1516-4446-2015-1716

Cited by 3 publications

(6 citation statements)

References 5 publications

(1 reference statement)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Neurodevelopmental disorders, defined as disorders caused by changes in early brain development resulting in behavioral and cognitive alterations, changes in sensory and motor systems, and speech and language deficits, affect roughly 1–2% of the population . The prevalence and expression of SIBs in children with NDDs is variable.…”

Section: Review Of Select Specific Neurodevelopmental Disordersa Assomentioning

confidence: 99%

“…Other contributing factors may include comorbid medical conditions such as urinary incontinence, pain, constipation, headache, menstruation, and depression . SIBs may be observed as early as 6 months of age in children with NDDs, gaining full expression by the age of 5 years, and may persist throughout the life span . The impact of SIBs on the patient as well as caregivers is profound, with SIBs commonly reported as one of the most negative influences on quality of life .…”

Section: Review Of Select Specific Neurodevelopmental Disordersa Assomentioning

confidence: 99%

“…SIBs may be observed as early as 6 months of age in children with NDDs, gaining full expression by the age of 5 years, and may persist throughout the life span . The impact of SIBs on the patient as well as caregivers is profound, with SIBs commonly reported as one of the most negative influences on quality of life . Clinical, social, financial, and emotional burdens are high .…”

Section: Review Of Select Specific Neurodevelopmental Disordersa Assomentioning

confidence: 99%

See 2 more Smart Citations

Management of Self‐injurious Behaviors in Children with Neurodevelopmental Disorders: A Pharmacotherapy Overview

et al. 2019

View full text Add to dashboard Cite

Neurodevelopmental disorders (NDDs), a group of disorders affecting ~1–2% of the general population, are caused by changes in brain development that result in behavioral and cognitive alterations, sensory and motor changes, and speech and language deficits. Neurodevelopmental disorders encompass a heterogeneous group of disorders including, but not limited to, Smith‐Magenis syndrome, Lesch‐Nyhan disease, cri du chat syndrome, Prader‐Willi syndrome, pervasive developmental disorders, fragile X syndrome, Rett syndrome, Cornelia de Lange syndrome, and Down syndrome. Self‐injurious behaviors (SIBs) are common in children with NDDs; depending on the specific NDD, the incidence of SIBs is nearly 100%. The management of SIBs in this population is complex, and little high‐quality data exist to guide a consistent approach to therapy. However, managing SIBs is of the utmost importance for the child as well as the family and caregivers. Behavior therapies must be implemented as first‐line therapy. If behavioral interventions alone fail, pharmacotherapy becomes an essential part of management plans. The limited available evidence for the use of common pharmacologic agents, such as second‐generation antipsychotics, and less common agents, such as clonidine, n‐acetylcysteine, riluzole, naltrexone, and topical anesthetics, is reviewed. Additional data from well‐designed studies in children with NDDs are needed to gain a better understanding of this common and troublesome problem including efficacy and safety implications associated with pharmacotherapy. Until then, clinicians must rely on the limited available data, clinical expertise, and ongoing systematic monitoring when managing SIBs in children with NDDs.

show abstract

Section: Review Of Select Specific Neurodevelopmental Disordersa Assomentioning

confidence: 99%

Section: Review Of Select Specific Neurodevelopmental Disordersa Assomentioning

confidence: 99%

Section: Review Of Select Specific Neurodevelopmental Disordersa Assomentioning

confidence: 99%

See 1 more Smart Citation

Management of Self‐injurious Behaviors in Children with Neurodevelopmental Disorders: A Pharmacotherapy Overview

et al. 2019

View full text Add to dashboard Cite

show abstract

“…These disorders are associated with difficulties in sensory and motor processing, and also have speech and language deficits and are seen in approximately 1%-2% of the population. 1,2 that ASD symptoms occur due to disruption in particular genes, like the Shank3 gene. 3 The characteristics of self-injurious behavior include that it is self-inflicted, non-lethal, non-suicidal, non-accidental act which results in tissue damage.…”

Section: Introductionmentioning

confidence: 99%

“…The impact of SIB on the caregivers as well as the patient is tremendous and often causes a lot of socioeconomic and emotional burden, in result having a negative impact on the quality of life. 1,2 Due to this, patients, caregivers and therapists are continuously trying for methods to offer relief from these behaviors. In this narrative review, we intend to focus on the symptomatology, causal and risk factors for SIBs along with the nonpharmacological and pharmacological management of SIBs in NDD.…”

Section: Introductionmentioning

confidence: 99%

An Overview of Managing Self-injurious Behaviors in Neurodevelopmental Disorders

Sawant,

Shukla

2023

Journal of Indian Association for Child and Adolescent Mental H

View full text Add to dashboard Cite

Self-injurious behavior is a common symptom in neurodevelopmental disorders which is often the least understood and difficult to treat. In this narrative review, we intend to focus on the symptomatology, causal and risk factors for SIBs along with the nonpharmacological and pharmacological management of SIBs in NDD. A manual search was done using the electronic databases of Pubmed, Google scholar on relevant publications or cross-references till December 2022 and the data was then collated to give the prevalence, epidemiology, risk factors, treatment and management of SIB in NDD. Results showed that the behaviors begin in developmental phase and are seen in nearly 30% of children with NDD. Many SIBs become chronic over time and are characterized by being repetitive in nature, compulsive or episodic. They could be superficial or deep and are best treated by nonpharmacological methods using functional behavior assessment (FBA). Despite lack of robust evidence for psychotropics some second-generation antipsychotics have been approved for pharmacological treatment of SIB. We can conclude that until more data are available, clinicians must continue to rely upon the limited available evidence, clinical judgement, and expertise, and carefully monitored response(s) to therapy when managing SIBs in children. SIB is outcome of multiple factors that initiate and maintain the behavior. Judicious use of various groups of pharmacological agents is advised. Physician preferences, history of response and safety are part of pharmacological interventions.

show abstract

The evolution of self-injurious behaviors in people with intellectual disability and epilepsy: A follow-up study

Buono

Zagaria

Recupero

et al. 2020

Seizure

View full text Add to dashboard Cite

Prevalence of self-injurious behavior in people with intellectual development disorder

Cited by 3 publications

References 5 publications

Management of Self‐injurious Behaviors in Children with Neurodevelopmental Disorders: A Pharmacotherapy Overview

Management of Self‐injurious Behaviors in Children with Neurodevelopmental Disorders: A Pharmacotherapy Overview

An Overview of Managing Self-injurious Behaviors in Neurodevelopmental Disorders

The evolution of self-injurious behaviors in people with intellectual disability and epilepsy: A follow-up study

Contact Info

Product

Resources

About